Laryngitis after inhalation of liposomal amikacin.
Atsuho MoritaHo NamkoongMakoto HosoyaNaoki HasegawaPublished in: Clinical case reports (2022)
A 56-year-old woman with pulmonary Mycobacterium avium complex disease was started on inhalation liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after treatment discontinuation, and no recurrence occurred even after resuming intermittent inhalation.
Keyphrases